Agenus | AGEN - Credores Comerciais





Credores Comerciais Alterar Data
AbbVie USD 3.59B 28.65B 2025-12
Agenus USD 58.98M 12.1M 2026-06
Amgen USD 2.86B 16.65B 2026-06
AstraZeneca USD 22.89B 388M 2026-06
Bristol-Myers Squibb USD 4.16B 76M 2026-06
Celldex Therapeutics USD 14.68M 4.32M 2026-06
CSL USD 3.17B 290M 2025-12
Eli Lilly USD 6.11B 1.08B 2026-06
Gilead Sciences USD 645M 70M 2026-03
GlaxoSmithKline GBP 14.34B 7M 2026-06
Glaxosmithkline GBP 14.34B 6.39B 2026-03
Incyte USD 1.39B 1.16B 2026-06
Intrexon USD 4.85M 3.12M 2024-06
J&J USD 9.22B 1.24B 2026-06
Jiangsu Hengrui CNY 2.03B 305.59M 2026-06
Karyopharm Therapeutics USD 4.28M 276K 2026-03
MacroGenics USD 3.44M 845K 2026-06
Merck EUR 2.07B 61M 2026-06
Merck USD 3.83B 36M 2026-06
Northwest Biotherapeutics 31.58M 5.13M 2026-03
Novartis USD 4.26B 64M 2026-06
Novavax USD 22.94M 6.84M 2026-06
Pfizer USD 4.58B 75M 2026-06
Regeneron Pharmaceuticals USD 1.16B 132.2M 2026-06
Rigel Pharmaceuticals USD 3.85M 3.44M 2025-09
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Veracyte USD 8.02M 1.12M 2026-06